Close Menu

JP Morgan Healthcare Conference

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

NEW YORK (GenomeWeb News) – Laboratory Corporation of America is planning on expanding its portfolio of genomics-based diagnostics, CEO David King said this week at the JP Morgan Healthcare Conference.

NEW YORK (GenomeWeb News) - Illumina President and CEO Jay Flatley today introduced two new sequencing platforms, new technological advances in the firm’s optics and flow cells, and reported preliminary fourth quarter figures for the firm.

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference kicked off here Monday with several life science tools and diagnostic firms making presentations to investors and other attendees.

This story has been updated from a previous version to clarify Exact Sciences' FDA submission timeline.

This article has been updated from a previous version to clarify the company's reimbursement goals for 2013.

This article was originally published Jan. 8.

SAN FRANCISCO (GenomeWeb News) – The second day of this year's JP Morgan Healthcare Conference included presentations from a number of companies in the genomic technology and molecular diagnostic market.

SAN FRANCISCO — Illumina said today at the JP Morgan Healthcare conference here that it has acquired Moleculo, a Stanford University spinout that has been developing long-read sequencing technology.

This article has been updated from a previous version, which had incorrectly transposed the year-over-year and sequential growth percentages for fourth-quarter revenue.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.